0001567619-20-006723.txt : 20200318 0001567619-20-006723.hdr.sgml : 20200318 20200318204635 ACCESSION NUMBER: 0001567619-20-006723 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200316 FILED AS OF DATE: 20200318 DATE AS OF CHANGE: 20200318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAWLIS V BRYAN CENTRAL INDEX KEY: 0001247681 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 20726211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2020-03-16 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001247681 LAWLIS V BRYAN C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 1 0 0 0 Common Stock 2020-03-16 4 S 0 4610 76.52 D 18980 D Common Stock 2020-03-17 4 M 0 3750 21.51 A 22730 D Common Stock 2020-03-17 4 S 0 3750 75.39 D 18980 D Stock Option (Right to buy Common Stock) 21.510 2020-03-17 4 M 0 3750 0 D 2010-11-12 2020-05-11 Common Stock 3750 0 D Trade made pursuant to a 10b5-1 plan executed on January 16, 2020. Trade made pursuant to a 10b5-1 plan executed on May 1, 2019. Reflects the number of options outstanding after the transactions from the specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2020-03-18